Literature DB >> 12054556

A single nucleotide polymorphism in the promoter region of the human gene for osteoprotegerin is related to vascular morphology and function.

Helena Brändström1, Fredrik Stiger, Lars Lind, Thomas Kahan, Håkan Melhus, Andreas Kindmark.   

Abstract

Osteoprotegerin (OPG) is a secreted member of the tumor necrosis factor receptor family, and has previously been shown to regulate bone mass by inhibiting osteoclast differentiation and activation. Recent evidence indicates that OPG also plays a role in the vascular system, since ablation of the OPG gene in mice results in calcification of the aorta and renal arteries, and association has been found between serum levels of OPG and cardiovascular mortality. This study presents a novel single nucleotide polymorphism, a T/C transition located 129 bp upstream the TATA-box of the human OPG gene, detected by sequence analysis. The OPG genotype was determined by restriction fragment length polymorphism in a cohort consisting of 59 healthy subjects. The intima-media thickness (IMT) in the common carotid artery and maximal post-ischemic forearm blood flow (FBF) were investigated. Subjects with the CC genotype showed a significantly increased IMT (p<0.05) and a concommitantly reduced maximal FBF (p<0.01) as compared to those with the T allele. Thus, our results show that the polymorphism in the promoter region of OPG is associated with both vascular morphology and function in apparently healthy subjects.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12054556     DOI: 10.1016/S0006-291X(02)00137-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  The genetics of response to estrogen treatment.

Authors:  Bente L Langdahl
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

Review 2.  The roles of lipid oxidation products and receptor activator of nuclear factor-κB signaling in atherosclerotic calcification.

Authors:  Linda Demer; Yin Tintut
Journal:  Circ Res       Date:  2011-06-10       Impact factor: 17.367

3.  Association of gene polymorphisms in RANKL/RANK/OPG system with hypertension and blood pressure in Chinese women.

Authors:  P Duan; Z-M Wang; J Liu; L-N Wang; Z Yang; P Tu
Journal:  J Hum Hypertens       Date:  2015-03-26       Impact factor: 3.012

Review 4.  Vascular calcification and osteoporosis--from clinical observation towards molecular understanding.

Authors:  L C Hofbauer; C C Brueck; C M Shanahan; M Schoppet; H Dobnig
Journal:  Osteoporos Int       Date:  2006-12-07       Impact factor: 4.507

5.  Decreased serum osteoprotegerin levels in patients with cardiac syndrome X.

Authors:  A Altun; B Ugur-Altun; E Tatli
Journal:  J Endocrinol Invest       Date:  2004-10       Impact factor: 4.256

6.  Meta-analysis of genome-wide association studies identifies two loci associated with circulating osteoprotegerin levels.

Authors:  Johnny S H Kwan; Yi-Hsiang Hsu; Ching-Lung Cheung; Josée Dupuis; Aude Saint-Pierre; Joel Eriksson; Samuel K Handelman; Aaron Aragaki; David Karasik; Peter P Pramstaller; Charles Kooperberg; Andrea Z Lacroix; Martin G Larson; Kam-Shing Lau; Mattias Lorentzon; Irene Pichler; Pak C Sham; Daniel Taliun; Liesbeth Vandenput; Douglas P Kiel; Andrew A Hicks; Rebecca D Jackson; Claes Ohlsson; Emelia J Benjamin; Annie W C Kung
Journal:  Hum Mol Genet       Date:  2014-07-30       Impact factor: 6.150

7.  Genetic regulation of atherosclerotic plaque size and morphology in the innominate artery of hyperlipidemic mice.

Authors:  Brian J Bennett; Susanna S Wang; Xuping Wang; Xiaohui Wu; Aldons J Lusis
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-01-02       Impact factor: 8.311

Review 8.  (Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis.

Authors:  Debby den Uyl; Mike T Nurmohamed; Lilian Hd van Tuyl; Hennie G Raterman; Willem F Lems
Journal:  Arthritis Res Ther       Date:  2011-01-17       Impact factor: 5.156

9.  Role of osteoprotegerin and its gene polymorphisms in the occurrence of left ventricular hypertrophy in essential hypertensive patients.

Authors:  Anna Shen; Xuwei Hou; Deguang Yang; Tingrong Liu; Dezhong Zheng; Liehua Deng; Tao Zhou
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

10.  A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer.

Authors:  Naofumi Narita; Takeshi Yuasa; Norihiko Tsuchiya; Teruaki Kumazawa; Shintaro Narita; Takamitsu Inoue; Zhiyong Ma; Mitsuru Saito; Yohei Horikawa; Shigeru Satoh; Osamu Ogawa; Tomonori Habuchi
Journal:  BMC Cancer       Date:  2008-08-06       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.